Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 29, Number 11—November 2023
Research

Prevalence of Undiagnosed Monkeypox Virus Infections during Global Mpox Outbreak, United States, June–September 2022

Faisal S. MinhajComments to Author , Vijay Singh, Stephanie E. Cohen, Michael B. Townsend, Hyman Scott, John Szumowski, C. Bradley Hare, Pallavi Upadhyay, Jairus Reddy, Barbara Alexander, Nicolle Baird, Terese Navarra, Lalita Priyamvada, Nhien Wynn, William C. Carson, Solomon Odafe, Sarah Anne J. Guagliardo, Emily Sims, Agam K. Rao, Panayampalli S. Satheshkumar, Paul J. Weidle1, and Christina L. Hutson1

Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (F.S. Minhaj, M.B. Townsend, N. Baird, T. Navarra, L. Priyamvada, N. Wynn, W.C. Carson; S. Odafe, S.A.J. Guagliardo, E. Sims; A.K. Rao, P.S. Satheshkumar, P.J. Weidle, C.L. Hutson); HealthTrackRx, Denton, Texas, USA (V. Singh, P. Upadhyay, J. Reddy, B. Alexander); San Francisco Department of Public Health, San Francisco, California, USA (S.E. Cohen, H. Scott); University of California San Francisco and Zuckerberg San Francisco General Hospital, San Francisco (J. Szumowski); Kaiser Permanente Northern California, San Francisco (C.B. Hare)

Main Article

Figure 2

Weekly positive detection of monkeypox virus by PCR testing and US Centers for Disease Control and Prevention case detection (https://www.cdc.gov/ecr/index.html), July 24–September 2, 2022. Results are from public health and select commercial laboratories and HealthTrackRx testing and US case detections. The greater number of laboratory positives than US case detections most likely results from testing of multiple samples from a single patient.

Figure 2. Weekly positive detection of monkeypox virus by PCR testing and US Centers for Disease Control and Prevention case detection (https://www.cdc.gov/ecr/index.html), July 24–September 2, 2022. Results are from public health and select commercial laboratories and HealthTrackRx testing and US case detections. The greater number of laboratory positives than US case detections most likely results from testing of multiple samples from a single patient.

Main Article

1These authors contributed equally to this article.

Page created: October 05, 2023
Page updated: October 23, 2023
Page reviewed: October 23, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external